1 / 8

Monkeypox Vaccine and Treatment Market (1)

The global monkeypox vaccine and treatment market was valued at USD 8.19 billion in 2022 and is expected to reach USD 19.68 billion in 2030, with a CAGR of 10.14% during the forecast period 2023-2030.

sonali58
Download Presentation

Monkeypox Vaccine and Treatment Market (1)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Monkeypox Vaccine and Treatment Market

  2. The monkeypox vaccine and treatment are used to address and prevent the monkeypox disease. These treatments provide therapeutic solutions for monkeypox disease. The monkeypox vaccine and treatment focuses on the development, manufacturing, and distribution of vaccines and treatments. These help manage monkeypox infections. • These vaccines can prevent monkeypox, as well as provide therapeutic options for patients those already infected. The market can fulfill the needs of the global healthcare sector for effective strategies against emerging infectious diseases, positioning itself as a crucial player in public health preparedness. The monkeypox vaccine and treatment market plays an important role in offering solutions to reduce the impact of this viral disease on individuals across the world. Download Sample PDF

  3. Market Drivers The rising prevalence of monkeypox, coupled with sporadic outbreaks, is a significant driver for the market. 1 Growing awareness and emphasis on global health security and preparedness contribute to the market's momentum. 2 2 2

  4. On the basis of gender, the sub-markets include male, female, and others. • On the basis of product, the sub-markets include vaccine, drugs, and vaccinia immune globulin (VIG). Market Segmentation 1 2 3 • On the basis of route of administration, the sub-markets include oral, and Injectables. 4 • On the basis of end-use, the sub-markets include hospitals, speciality clinics and others.

  5. Segmentation by Region

  6. Leading Market Players • Bavarian Nordic • SIGA Technologies • Chimerix, Inc. • Piramal Pharma Solutions • Gilead Sciences, Inc. • Elabscience Biotechnology Inc. • Goldsite Diagnostics Inc. • Emergent BioSolutions • Emergex Vaccines • Emcure Pharmaceuticals

  7. 2nd Floor, Ganadish Empire, Contact: Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027 Call Us: +91 99239 50043  Mail: info@infiniumglobalresearch.com Web: www.infiniumglobalresearch.com

  8. Thank You!!

More Related